1. Home >
  2. Investors >
  3. Growth Capital Firm >
  4. Netherlands >
  5. Icos Capital

Icos Capital Mergers and Acquisitions Summary

Growth Capital Firm Profile

In the last 3 years, Icos Capital has invested in 5 companies.

Icos Capital’s most common sectors for investment areenvironmental (38%) and life science (19%) . The Firm’s most common investment types include growth capital (82%) and venture (13%). In total, Icos Capital has invested in 5 different countries. Its largest (disclosed) acquisition occurred in 2011 when it acquired BioActor BV for $2M.

In the last 3 years, Icos Capital has exited 1 company. The Firm’s most common exit type is trade sale (100%).

Subscribe to Mergr to view Icos Capital’s full profile and discover more small growth capital firm investors just like it.

M&A Summary

  • M&A Total Activity17
    • M&A Buy Activity16
    • M&A Sell Activity1
  • Total Sectors Invested 8
  • Total Countries Invested 5
  • M&A Buy/Sell Connections 1

Icos Capital

Icos Capital Management BV

Marconistraat 16, 11th Floor,
Rotterdam, 3029 AK
Netherlands
+31 10 8208 688
www.icoscapital.com
info@icoscapital.com

Icos Capital is a specialist private equity firm focused on investments in clean technology. Icos looks for European companies that offer new, alternative scarce resources (water, energy) and more efficient industrial and consumer products. The firm looks to provide growth capital in the form of minority investments. Icos' target investment size is €1 to €5 million. Icos Capital is headquartered in Rotterdam, Netherlands.


Investment Criteria

Sectors of Interest: Chemicals, Consumer Products, Environmental, Food, Test/Measurement Equipment

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Venture

Geographic Preferences: Western Europe, Eastern Europe

Transaction Criteria Min Max
Target Revenue 1 5
Target EBITDA - -
Investment Size 1 5
Enterprise Value - -
values in millions of EUR

M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (1.4/yr) # 9 2 - 1 4 - 16
vol $2M $2M
Sell (0.2/yr) # - - - 1 - - 1
  17

Most Recent M&A

Company Date Value Type
Abolis Biotechnologies 2024-09-12 - Growth Capital
Evry, France · www.abolis.fr
PEF Technologies BV 2024-08-16 - Growth Capital
Enschede, Netherlands · www.pef-technologies.nl
NapiFeryn BioTech Sp. z o.o. 2024-01-30 - Growth Capital
Lodz, Poland · www.napiferyn.com
Fotoniq Technologies BV 2024-01-18 - Growth Capital
Delft, Netherlands · www.fotoniq.com
eAgronom OU 2023-05-27 - Growth Capital
Tallinn, Estonia · www.eagronom.com
BioActor BV 2023-01-12 - Trade Sale
Maastricht, Netherlands · www.bio-actor.com
WholeFiber BV 2021-09-23 - Growth Capital
Emmeloord, Netherlands · www.wholefiber.nl
Invert Robotics Group Ltd. 2021-04-28 - Growth Capital
Dublin, Ireland · www.invertrobotics.com
Photanol BV 2012-08-01 - Venture
Amsterdam, Netherlands · www.photanol.com
BioActor BV 2011-07-25 2M EUR Venture
Maastricht, Netherlands · www.bio-actor.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Environmental 1 (11%) - 6 (38%) -
Life Science 2 (22%) - 3 (19%) -
Chemicals 2 (22%) - 2 (13%) -
Consumer Products - - 1 (6%) 2M (100%)
Food 1 (11%) - 1 (6%) -
Internet Software and Services 1 (11%) - 1 (6%) -
Machinery 1 (11%) - 1 (6%) -
Software 1 (11%) - 1 (6%) -
Total 9 - 16 $2M

Acquisitions By Geo

State/Country Current # Value All-time # Value
Netherlands 5 (56%) - 12 (75%) 2M (100%)
France 1 (11%) - 1 (6%) -
Estonia 1 (11%) - 1 (6%) -
Ireland 1 (11%) - 1 (6%) -
Poland 1 (11%) - 1 (6%) -
Total 9 - 16 $2M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Growth Capital 8 (89%) - 13 (81%) -
Venture 1 (11%) - 2 (13%) 2M (100%)
Buyout (LBO, MBO, MBI) - - 1 (6%) -
Total 9 - 16 $2M

Exits by Deal Type

Type Total # Value
Trade Sale 1 (100%) -
Total 1 -

Deal Values

buy # Total
< $100M 1 $2M
TOTAL $2M
Largest BioActor BV
$2M (2011-07-25)

M&A Connections

Deals
Exited to
Strategic(s)
100%
1 (100%)

Investor Summary

Investor Type

Growth Capital Firm

Size

Small

Established

2005

Specialist/Generalist

Specialist

Leadership

Nityen Lal

General Partner

Peter van Gelderen

General Partner

Rudi Dupper

CFO

Ewelina Kuna

Principal, Sustainable Industry

Katarzyna Gil

Principal, Sustainable Industry

FAQ

When was Icos Capital founded?

Icos Capital was founded in 2005.

What type of investor is Icos Capital?

Icos Capital is a growth capital firm.

Where is Icos Capital headquartered?

Icos Capital is headquartered in Rotterdam, Netherlands.

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal